ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,751.07
0.90%
Dow Jones
42,352.75
0.81%
US Dollar vs MXN
19.287
0.00%
Brent Oil
77.97
0.00%
Bitcoin
62,133.83
0.10%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Bright Minds Biosciences Inc (DRUG) Cotización

Bright Minds Biosciences Inc

Bright Minds Biosciences Inc (DRUG)

BetaShares Capital Limited
Bright Minds Biosciences Inc
1.16
0.07
(6.42%)
Cerrado 04 Octubre 3:00PM
Delayed by 15 minutes
1.16
0.00
(0.00%)
Fuera de horario: 5:56PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
1.16
Postura de Compra
1.06
Postura de Venta
1.21
Volume Operado de la Acción
1,845
1.11 Rango del Día 1.16
0.93 Rango de 52 semanas 2.39
Capitalización de Mercado [m]
5.178M
Precio Anterior
1.09
Precio de Apertura
1.11
Hora
1
@
1.16
Última hora de negociación
Volumen financiero
US$ 2,078
Precio Promedio Ponderado
1.1265
Volumen promedio (3 m)
112,630
Acciones en circulación
4,463,837
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.70
Beneficio por acción (BPA)
-1.65
turnover
-
Beneficio neto
-7.37M

Acerca de Bright Minds Biosciences Inc

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.brightmindsbio.com
Sede
Vancouver, British Columbia, Can
Fundado
-
Bright Minds Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRUG. The last closing price for Bright Minds Biosciences was US$1.09. Over the last year, Bright Minds Biosciences shares have traded in a share price range of US$ 0.93 to US$ 2.39.

Bright Minds Biosciences currently has 4,463,837 shares in issue. The market capitalisation of Bright Minds Biosciences is US$4.87 million. Bright Minds Biosciences has a price to earnings ratio (PE ratio) of -0.70.

DRUG Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

03 Octubre 2024
Edgar (US Regulatory)

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202Bright Minds Biosciences will participate in BIO Europe...

03 Octubre 2024
GlobeNewswire Inc.

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on...

19 Septiembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Septiembre 2024
Edgar (US Regulatory)

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy PR Newswire NEW YORK, Sept. 12, 2024 Bright...

12 Septiembre 2024
PR Newswire (US)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

26 Febrero 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

26 Febrero 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Febrero 2024
Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership

18 Enero 2024
Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

29 Diciembre 2023
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.05-4.132231404961.211.241.065113051.10543186CS
40.05535.005883950391.10471.41.065188001.21059656CS
120.190119.59995875860.96991.750.96011126301.29682809CS
26-0.16-12.12121212121.321.750.93589601.27665795CS
52-0.46-28.39506172841.622.390.93435481.39040041CS
156-43.59-97.407821229144.7544.750.93127916410.28968578CS
260-43.59-97.407821229144.7544.750.93127916410.28968578CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CHSNChanson International Holding
US$ 11.22
(269.08%)
14.84M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
223.68M
ENTOEntero Therapeutics Inc
US$ 0.60
(72.20%)
10.42M
BENFBeneficient
US$ 1.8914
(58.94%)
101M
FORDForward Industries Inc
US$ 5.3254
(52.15%)
17.67M
ADDColor Star Technology Company Ltd
US$ 0.2701
(-39.98%)
14.35M
DUOFangDD Network Group Ltd
US$ 2.53
(-32.89%)
27.74M
ICCTiCoreConnect Inc
US$ 0.4102
(-31.50%)
1.65M
ZENAZenaTech Inc
US$ 3.91
(-29.55%)
212.12k
SPAISafe Pro Group Inc
US$ 1.93
(-25.77%)
238.67k
NVDANVIDIA Corporation
US$ 124.92
(1.68%)
234.27M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
223.68M
SQQQProShares UltraPro Short QQQ
US$ 7.43
(-3.63%)
175.65M
NCNCnoco noco Inc
US$ 0.144
(8.60%)
141.12M
BENFBeneficient
US$ 1.8914
(58.94%)
101M

DRUG Discussion

Ver más
Smilin_B Smilin_B 1 mes hace
genius
👍️0
Monksdream Monksdream 1 mes hace
DRUG under $2
👍️0
Banjo50 Banjo50 1 mes hace
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
glenn1919 glenn1919 1 mes hace
DRUG...........................https://stockcharts.com/h-sc/ui?s=DRUG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 meses hace
DRUG under $2
👍️0
tw0122 tw0122 4 meses hace
Ready for lift off
👍️0
Monksdream Monksdream 6 meses hace
DRUG new 52 lo
👍️0
Monksdream Monksdream 7 meses hace
DRUG under $2
👍️0
Monksdream Monksdream 7 meses hace
SAP new 52 week high
👍️0
Smilin_B Smilin_B 7 meses hace
I'm assuming there's always a dark cloud over-head in your life on a daily basis
👍️0
Monksdream Monksdream 7 meses hace
DRUG under $2
👍️0
Smilin_B Smilin_B 11 meses hace
Do you enjoy doing this?
👍️0
Monksdream Monksdream 11 meses hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 11 meses hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 1 año hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 1 año hace
DRUG under $2
👍️0
Monksdream Monksdream 1 año hace
At present the reefer stocks are getting the bulls attention
As far as I know no psychedelic stock has produced a 10,000 percent return the way some reefer stocks did about five years ago
👍️0
DJS1 DJS1 1 año hace
Those greedy shorts will be paying soon.
No reason whatsoever for it to be at this level
👍️0
Monksdream Monksdream 1 año hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 1 año hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 1 año hace
DRUG new 52 week low
👍️0
Monksdream Monksdream 1 año hace
DRUG new 52 week low
👍️0
DJS1 DJS1 1 año hace
Holding strong all of my shares. I think the next run will surpass the momentum run that we had a week or so ago. September is upon us and history repeats itself. Very positive results with the clinical trial.

$DRUG
👍️0
Smilin_B Smilin_B 1 año hace
$7.80 down to $2.50s in 3 sessions
👍️0
DJS1 DJS1 1 año hace
Timothy Sykes crew shorting this
👍️0
Smilin_B Smilin_B 1 año hace
Down an additional 23% today

Simply incredible
👍️0
Smilin_B Smilin_B 1 año hace
I was actually at a break-even and decent profit in the pre-market yesterday but didn't pull the trigger to sell, because I recall the insane amount of short interest in this ticker and was hoping for some follow through during the session and in after-hours

But...that never happened.

Volume was completely incredible however, so it's safe to say we have a lot of fresh blood in this over $4 & $5/share
👍️0
SriMaharaj SriMaharaj 1 año hace
Looks like it will continue to go down since no new update from conference call. Also, there was no Q&A session for investor. It was just recording session.
👍️0
Smilin_B Smilin_B 1 año hace
-17.5% pre market

$3.44
👍️0
Smilin_B Smilin_B 1 año hace
From up over 100% pre-market to up only 18%.

Basically anyone that purchased shares today is at an incredible loss just in one session
👍️0
Smilin_B Smilin_B 1 año hace
The issue the press release explaining everything. They only have conference calls in case shareholders, potential investors, hedge fund managers and others have questions. I did not listen to the call so I do not know what the end result was but apparently it was nothing new outside of what was issued in the press release pre-market
👍️0
SriMaharaj SriMaharaj 1 año hace
It's shame on management. Why do they do conference call if there is nothing new to say.
👍️0
Smilin_B Smilin_B 1 año hace
$7.80 pre market

$3.73 after hrs

Definitely not what I was anticipating after an excellent news release and after hours conference call
👍️0
Smilin_B Smilin_B 1 año hace
30.6 MILLION shares exchanged hands today

2.9M share float????

3.8M shares in the OS ????
👍️0
Smilin_B Smilin_B 1 año hace
This forum is super active on twits but no one is posting here - volume is insane in relation to DRUG's O/S
👍️0
SriMaharaj SriMaharaj 1 año hace
I am hoping for good news during the call and analyst coverage after the call. I believe there might be an analyst coverage coming out after today's call.
👍️0
Smilin_B Smilin_B 1 año hace
From a high of $7.80 in pre-market down to $4 right now = no bueno
👍️0
Smilin_B Smilin_B 1 año hace
This was up over 100% earlier today
👍️0
SriMaharaj SriMaharaj 1 año hace
I told you guys. Consolidation is over. It's going to go up from here. Shories are in trouble.
👍️0
Smilin_B Smilin_B 1 año hace
Depends if there's a little more positive info released in today's conference call after hours
👍️0
SriMaharaj SriMaharaj 1 año hace
I believe this will go up from here. Selling is over and shorts are going to get into trouble after today's conference call.
👍️0
Smilin_B Smilin_B 1 año hace
Posting is DEAD in here today
👍️0
Smilin_B Smilin_B 1 año hace
Lots of profit taking by longs this morning. Let's see what comes of the conference call today at 430pm
👍️0
Smilin_B Smilin_B 1 año hace
That must have been nice to see pre market
👍️0
Smilin_B Smilin_B 1 año hace
Shorts won't be disturbed until the $7-8 area
👍️0
Smilin_B Smilin_B 1 año hace
Company to host webcast to discuss findings of the Phase 1 study today, August 8, 2023, at 4:30pm ET
👍️0
DJS1 DJS1 1 año hace
Bye bye shorties!!!
👍️0
Monksdream Monksdream 1 año hace
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️ 1
Jess070283 Jess070283 1 año hace
Wonderful News!
👍️0
DJS1 DJS1 1 año hace
Just jumped to $7.33
👍️0

Su Consulta Reciente

NASDAQ
DRUG
Bright Minds Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados